A narrative review on serum biomarkers of cardiac fibrosis
Myocardial fibrosis is the excessive deposition of extracellular matrix (ECM) proteins in the cardiac interstitium leading to pathological conditions of the heart. The objective is to understand the pathophysiology of cardiac fibrosis and the quest for serum biomarkers that will assist in early diag...
Main Authors: | Santoshi Kumari, Urvashi Sharma, Deepika Jindal, Traymbak Basak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of the Practice of Cardiovascular Sciences |
Subjects: | |
Online Access: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2023;volume=9;issue=1;spage=24;epage=36;aulast=Kumari |
Similar Items
-
Linking LOXL2 to Cardiac Interstitial Fibrosis
by: Melisse Erasmus, et al.
Published: (2020-08-01) -
Human Lysyl Oxidase Over-Expression Enhances Baseline Cardiac Oxidative Stress but Does Not Aggravate ROS Generation or Infarct Size Following Myocardial Ischemia-Reperfusion
by: Laura Valls-Lacalle, et al.
Published: (2021-12-01) -
Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis
by: Yimin Yao, et al.
Published: (2022-05-01) -
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis
by: Mark G Jones, et al.
Published: (2018-07-01) -
Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway
by: Zhen Hai, et al.
Published: (2023-11-01)